LA MIRADA, CA--(Marketwire - Mar 4, 2013) - BioLargo, Inc. (
"With the recent introduction of our Nature's Best Solution® line of feline products and Free Iodine Skin and Wound Care products for pets, hiring the best agency was a top priority," said Dennis Calvert, BioLargo's president. "With more than 2,000 employees nationwide, and a reputation as the industry's top agency, we believe The Pet Firm gives us another key advantage as we work to place our products with leading pet retailers."
BioLargo's wholly owned subsidiary, Odor-No-More, Inc., introduced its Nature's Best Solution® feline products and its Free Iodine Skin and Wound Care Products at the recent Global Pet Expo trade show in Orlando, Florida. "We are excited to get started working with BioLargo's portfolio of products. The use of science and technology to produce truly next generation products is exciting!" stated Greg Melin, VP of Sales & New Business Development of The Pet Firm.
Odor-No-More's president, Joseph Provenzano, added "our products were well received at the show by pet retailers and industry members because they are searching for a product that actually works." Caroline Golan, a lifestyle writer and blogger from Catster.com, picked the Nature's Best Solution® Litterbox Deodorizing Concentrate as one of the "Ten Most Intriguing Cat Products" at the Global Pet Expo. In her article she states "this stuff works really well!"
For more information about the Nature's Best Solution® Pet Care Line visit www.NaturesBestSolution.com.
About BioLargo, Inc.
We make life better by delivering technology-based products that help solve some of the world's most important problems that threaten our water, food, agriculture, healthcare and energy. Our website is http://www.BioLargo.com. Our Odor-No-More Inc. subsidiary features award-winning products serving the companion animal and equine markets, including the Nature's Best Solution® and Deodorall® brands. (http://www.OdorNoMore.com). BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. Our subsidiary, Clyra Medical Technologies, Inc., focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2013.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K for the year ended December 31, 2011.